BioMarin Pharmaceutical Inc. (BMRN)

BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of $15.97 billion as of July 22, 2024. Its market cap has decreased by -0.62% in one year.

• Market Cap: 15.97B
• Enterprise Value: 16.01B
• 1-Year Change: -0.62%
• Ranking: #627
• Category: Large-Cap
• Stock Price: $84.09

Market Cap Chart

Since July 26, 1999, BioMarin Pharmaceutical's market cap has increased from $443.40M to $15.97B, an increase of 3,501.04%. That is a compound annual growth rate of 15.41%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	15.97B	-12.09%
Dec 29, 2023	18.16B	-5.57%
Dec 30, 2022	19.23B	18.58%
Dec 31, 2021	16.22B	1.90%
Dec 31, 2020	15.92B	4.81%
Dec 31, 2019	15.19B	0.17%
Dec 31, 2018	15.16B	-3.18%
Dec 29, 2017	15.66B	9.92%
Dec 30, 2016	14.25B	-15.66%
Dec 31, 2015	16.89B	26.72%
Dec 31, 2014	13.33B	33.25%
Dec 31, 2013	10.00B	64.58%
Dec 31, 2012	6.08B	54.81%
Dec 30, 2011	3.93B	42.26%
Dec 31, 2010	2.76B	45.68%
Dec 31, 2009	1.89B	6.63%
Dec 31, 2008	1.78B	-48.15%
Dec 31, 2007	3.43B	128.90%
Dec 29, 2006	1.50B	87.98%
Dec 30, 2005	796.50M	93.28%
Dec 31, 2004	412.10M	-16.92%
Dec 31, 2003	496.00M	31.08%
Dec 31, 2002	378.40M	-36.33%
Dec 31, 2001	594.30M	67.03%
Dec 29, 2000	355.80M	-13.05%

View and export this data all the way back to 1999. Sign Up Today.

Related Stocks

Company	Market Cap
Waters	17.96B
Labcorp Holdings	17.82B
BeiGene	17.25B
Molina Healthcare	16.90B
Quest Diagnostics	16.22B
Incyte	14.81B
Neurocrine Biosciences	14.66B
United Therapeutics	14.60B